Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Efficacy and tolerability of a once daily formulation of Ginkgo biloba extract EGb 761® in Alzheimer's disease and vascular dementia: results from a randomised controlled trial.

Ihl R, Tribanek M, Bachinskaya N; GOTADAY Study Group.

Pharmacopsychiatry. 2012 Mar;45(2):41-6. doi: 10.1055/s-0031-1291217. Epub 2011 Nov 15.

PMID:
22086747
[PubMed - indexed for MEDLINE]
2.

Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial.

Napryeyenko O, Sonnik G, Tartakovsky I.

J Neurol Sci. 2009 Aug 15;283(1-2):224-9. doi: 10.1016/j.jns.2009.02.353. Epub 2009 Mar 14.

PMID:
19286192
[PubMed - indexed for MEDLINE]
3.

Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.

Herrschaft H, Nacu A, Likhachev S, Sholomov I, Hoerr R, Schlaefke S.

J Psychiatr Res. 2012 Jun;46(6):716-23. doi: 10.1016/j.jpsychires.2012.03.003. Epub 2012 Mar 27.

PMID:
22459264
[PubMed - indexed for MEDLINE]
4.

Ginkgo biloba special extract in dementia with neuropsychiatric features. A randomised, placebo-controlled, double-blind clinical trial.

Napryeyenko O, Borzenko I; GINDEM-NP Study Group.

Arzneimittelforschung. 2007;57(1):4-11.

PMID:
17341003
[PubMed - indexed for MEDLINE]
5.

Effects of Ginkgo biloba extract EGb 761 on neuropsychiatric symptoms of dementia: findings from a randomised controlled trial.

Scripnikov A, Khomenko A, Napryeyenko O; GINDEM-NP Study Group.

Wien Med Wochenschr. 2007;157(13-14):295-300.

PMID:
17704975
[PubMed - indexed for MEDLINE]
6.

Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.

Ihl R, Bachinskaya N, Korczyn AD, Vakhapova V, Tribanek M, Hoerr R, Napryeyenko O; GOTADAY Study Group.

Int J Geriatr Psychiatry. 2011 Nov;26(11):1186-94. doi: 10.1002/gps.2662. Epub 2010 Dec 7.

PMID:
21140383
[PubMed - indexed for MEDLINE]
7.

Baseline neuropsychiatric symptoms are effect modifiers in Ginkgo biloba extract (EGb 761®) treatment of dementia with neuropsychiatric features. Retrospective data analyses of a randomized controlled trial.

Ihl R, Tribanek M, Bachinskaya N.

J Neurol Sci. 2010 Dec 15;299(1-2):184-7. doi: 10.1016/j.jns.2010.08.033. Epub 2010 Sep 15.

PMID:
20837354
[PubMed - indexed for MEDLINE]
8.

Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study.

Mazza M, Capuano A, Bria P, Mazza S.

Eur J Neurol. 2006 Sep;13(9):981-5.

PMID:
16930364
[PubMed - indexed for MEDLINE]
9.

A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.

Le Bars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg AF.

JAMA. 1997 Oct 22-29;278(16):1327-32.

PMID:
9343463
[PubMed - indexed for MEDLINE]
10.

Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial.

Kanowski S, Hoerr R.

Pharmacopsychiatry. 2003 Nov;36(6):297-303.

PMID:
14663654
[PubMed - indexed for MEDLINE]
11.

Response patterns of EGb 761 in Alzheimer's disease: influence of neuropsychological profiles.

Le Bars PL.

Pharmacopsychiatry. 2003 Jun;36 Suppl 1:S50-5.

PMID:
13130389
[PubMed - indexed for MEDLINE]
12.

Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.

Bachinskaya N, Hoerr R, Ihl R.

Neuropsychiatr Dis Treat. 2011;7:209-15. doi: 10.2147/NDT.S18741. Epub 2011 Apr 20.

PMID:
21573082
[PubMed]
Free PMC Article
13.

The efficacy of ginkgo for elderly people with dementia and age-associated memory impairment: new results of a randomized clinical trial.

van Dongen MC, van Rossum E, Kessels AG, Sielhorst HJ, Knipschild PG.

J Am Geriatr Soc. 2000 Oct;48(10):1183-94.

PMID:
11037003
[PubMed - indexed for MEDLINE]
14.

Effects of Ginkgo biloba extract EGb 761 ® in dementia with neuropsychiatric features: review of recently completed randomised, controlled trials.

Ihl R.

Int J Psychiatry Clin Pract. 2013 Nov;17 Suppl 1:8-14. doi: 10.3109/13651501.2013.814796. Epub 2013 Aug 27. Review.

PMID:
23808613
[PubMed - indexed for MEDLINE]
15.

Ginkgo biloba extract EGb 761(R), donepezil or both combined in the treatment of Alzheimer's disease with neuropsychiatric features: a randomised, double-blind, exploratory trial.

Yancheva S, Ihl R, Nikolova G, Panayotov P, Schlaefke S, Hoerr R; GINDON Study Group.

Aging Ment Health. 2009 Mar;13(2):183-90. doi: 10.1080/13607860902749057.

PMID:
19347685
[PubMed - indexed for MEDLINE]
16.

Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial.

Black S, Román GC, Geldmacher DS, Salloway S, Hecker J, Burns A, Perdomo C, Kumar D, Pratt R; Donepezil 307 Vascular Dementia Study Group.

Stroke. 2003 Oct;34(10):2323-30. Epub 2003 Sep 11.

PMID:
12970516
[PubMed - indexed for MEDLINE]
Free Article
17.

Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial.

van Dongen M, van Rossum E, Kessels A, Sielhorst H, Knipschild P.

J Clin Epidemiol. 2003 Apr;56(4):367-76.

PMID:
12767414
[PubMed - indexed for MEDLINE]
18.

Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.

Kanowski S, Herrmann WM, Stephan K, Wierich W, Hörr R.

Pharmacopsychiatry. 1996 Mar;29(2):47-56.

PMID:
8741021
[PubMed - indexed for MEDLINE]
19.

Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trials.

Passmore AP, Bayer AJ, Steinhagen-Thiessen E.

J Neurol Sci. 2005 Mar 15;229-230:141-6. Epub 2005 Jan 6.

PMID:
15760632
[PubMed - indexed for MEDLINE]
20.

A 12-month, randomized, placebo-controlled trial of propentofylline (HWA 285) in patients with dementia according to DSM III-R. The European Propentofylline Study Group.

Marcusson J, Rother M, Kittner B, Rössner M, Smith RJ, Babic T, Folnegovic-Smalc V, Möller HJ, Labs KH.

Dement Geriatr Cogn Disord. 1997 Sep-Oct;8(5):320-8.

PMID:
9298634
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk